Two human IgM myeloma proteins with unusual specificities for streptococcal carbohydrate-associated epitopes. 1985

F Emmrich, and D Bundle, and J van der Zee, and T Out, and G Zenke, and K Eichmann

Five hundred and fifty human sera from patients with IgM myeloma or Waldenström's macroglobulinaemia were screened by a solid-phase enzyme-linked immunoassay for binding to the carbohydrate of group A streptococci (A-CHO). Two of them (AC8 and AC179) contained immunoglobulin, which bound specifically to A-CHO even at serum dilutions of 1:10(7). Using synthetic oligosaccharides coupled to protein for inhibition studies, the fine specificities of AC8 and AC179 were determined. AC179 is directed to alpha-linked rhamnose oligosaccharides. AC8 appears to be specific for N-acetyl-D-glucosamine (GlcNAc) side chains beta(1----2)-linked to rhamnose, whereas GlcNAc side chains in A-CHO are reported to be beta(1----3)-linked to the rhamnose backbone. Naturally occurring anti-A-CHO antibodies consist mainly of low-affinity antibodies to such beta(1----3)-linked GlcNAc. In contrast, both myeloma antibodies show more than 10 times higher relative affinities to A-CHO than antibodies prepared from normal human serum (anti-GlcNAc and anti-A-CHO, respectively) by selection for high affinity in the elution procedure. AC179 induced complement activation in the presence of A-CHO.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D009194 Myeloma Proteins Abnormal immunoglobulins characteristic of MULTIPLE MYELOMA. M Components,Proteins, Myeloma
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D003172 Complement C1 The first complement component to act in the activation of CLASSICAL COMPLEMENT PATHWAY. It is a calcium-dependent trimolecular complex made up of three subcomponents: COMPLEMENT C1Q; COMPLEMENT C1R; and COMPLEMENT C1S at 1:2:2 ratios. When the intact C1 binds to at least two antibodies (involving C1q), C1r and C1s are sequentially activated, leading to subsequent steps in the cascade of COMPLEMENT ACTIVATION. C1 Complement,Complement 1,Complement Component 1,C1, Complement,Complement, C1,Component 1, Complement
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000117 Acetylglucosamine The N-acetyl derivative of glucosamine. Acetyl Glucosamine,N-Acetyl Glucosamine,N-Acetyl-beta-D-Glucosamine,N-Acetylglucosamine,beta-N-Acetylglucosamine,2-Acetamido-2-Deoxy-D-Glucose,2-Acetamido-2-Deoxyglucose,N-Acetyl-D-Glucosamine,2 Acetamido 2 Deoxy D Glucose,2 Acetamido 2 Deoxyglucose,Glucosamine, Acetyl,Glucosamine, N-Acetyl,N Acetyl D Glucosamine,N Acetyl Glucosamine,N Acetyl beta D Glucosamine,N Acetylglucosamine,beta N Acetylglucosamine
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial

Related Publications

F Emmrich, and D Bundle, and J van der Zee, and T Out, and G Zenke, and K Eichmann
January 1979, Reviews of infectious diseases,
F Emmrich, and D Bundle, and J van der Zee, and T Out, and G Zenke, and K Eichmann
December 1984, Revue francaise de transfusion et immuno-hematologie,
F Emmrich, and D Bundle, and J van der Zee, and T Out, and G Zenke, and K Eichmann
January 1981, Journal of immunological methods,
F Emmrich, and D Bundle, and J van der Zee, and T Out, and G Zenke, and K Eichmann
August 1985, The Journal of experimental medicine,
F Emmrich, and D Bundle, and J van der Zee, and T Out, and G Zenke, and K Eichmann
February 1970, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
F Emmrich, and D Bundle, and J van der Zee, and T Out, and G Zenke, and K Eichmann
September 1970, Immunochemistry,
F Emmrich, and D Bundle, and J van der Zee, and T Out, and G Zenke, and K Eichmann
March 2006, Journal of immunological methods,
F Emmrich, and D Bundle, and J van der Zee, and T Out, and G Zenke, and K Eichmann
September 1993, Journal of immunology (Baltimore, Md. : 1950),
F Emmrich, and D Bundle, and J van der Zee, and T Out, and G Zenke, and K Eichmann
November 1970, Journal of immunology (Baltimore, Md. : 1950),
F Emmrich, and D Bundle, and J van der Zee, and T Out, and G Zenke, and K Eichmann
April 1989, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!